Germany Rows Back On Plans For Biosimilar Substitution

 
• By Aidan Fry
  
Pharmacist
Pharmacy-level substitution of biological drugs in Germany has been pushed back by at least three years in the latest draft of healthcare reforms • Source: Shutterstock

More from Biosimilars

More from Products